These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness. Davies L; McLeod JG; Muir A; Hensley WJ Clin Exp Neurol; 1987; 24():5-10. PubMed ID: 2478320 [TBL] [Abstract][Full Text] [Related]
3. The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases. Harrington MG; Kennedy PG Postgrad Med J; 1987 Sep; 63(743):735-40. PubMed ID: 3328189 [TBL] [Abstract][Full Text] [Related]
4. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877 [TBL] [Abstract][Full Text] [Related]
5. Myelin basic protein in the cerebrospinal fluid of patients with brain tumors. Nakagawa H; Yamada M; Kanayama T; Tsuruzono K; Miyawaki Y; Tokiyoshi K; Hagiwara Y; Hayakawa T Neurosurgery; 1994 May; 34(5):825-33; discussion 833. PubMed ID: 7519757 [TBL] [Abstract][Full Text] [Related]
6. Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. Sivieri S; Ferrarini AM; Lolli F; Matà S; Pinto F; Tavolato B; Gallo P J Neurol Sci; 1997 Mar; 147(1):93-5. PubMed ID: 9094066 [TBL] [Abstract][Full Text] [Related]
7. [Chronic inflammatory demyelinating polyradiculoneuropathy associated with central nervous system involvement--as compared to multiple sclerosis]. Komori T; Ohtake T; Miyazaki Y; Hirose K; Tanabe H Rinsho Shinkeigaku; 1990 Sep; 30(9):939-43. PubMed ID: 2265502 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416 [TBL] [Abstract][Full Text] [Related]
9. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies. Dorta-Contreras A; Silva-Somoza R Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970 [TBL] [Abstract][Full Text] [Related]
10. Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders. Chiang HL; Lyu RK; Tseng MY; Chang KH; Chang HS; Hsu WC; Kuo HC; Chu CC; Wu YR; Ro LS; Huang CC; Chen CM Clin Chim Acta; 2009 Jul; 405(1-2):143-7. PubMed ID: 19410571 [TBL] [Abstract][Full Text] [Related]
11. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661 [TBL] [Abstract][Full Text] [Related]
12. [The permeability of the hemato-encephalic barrier in neurological cancer patients in the postoperative period]. Kislitsyn IuV Zh Vopr Neirokhir Im N N Burdenko; 1999; (1):25-7; discussion 27-8. PubMed ID: 10335573 [TBL] [Abstract][Full Text] [Related]
13. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center. Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455 [TBL] [Abstract][Full Text] [Related]
14. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system. Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592 [TBL] [Abstract][Full Text] [Related]
15. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis. Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981 [TBL] [Abstract][Full Text] [Related]
16. Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal. Chalon MP; Sindic CJ; Laterre EC Acta Neurol Scand; 1993 Feb; 87(2):77-82. PubMed ID: 8442399 [TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels. Würz A; Brinkmeier H; Wollinsky KH; Mehrkens HH; Kornhuber HH; Rüdel R Muscle Nerve; 1995 Jul; 18(7):772-81. PubMed ID: 7783768 [TBL] [Abstract][Full Text] [Related]
18. [Cerebrospinal fluid findings in patients with acute and chronic inflammatory demyelinating polyradiculoneuropathies]. Drulović J; Apostolski S; Stojasavljević N; Trikić R; Sokić D; Lević Z Srp Arh Celok Lek; 1996; 124(1-2):1-5. PubMed ID: 9102806 [TBL] [Abstract][Full Text] [Related]
19. Neurosteroids in cerebrospinal fluid in neurologic disorders. Azuma T; Matsubara T; Shima Y; Haeno S; Fujimoto T; Tone K; Shibata N; Sakoda S J Neurol Sci; 1993 Dec; 120(1):87-92. PubMed ID: 8289085 [TBL] [Abstract][Full Text] [Related]